Prostate
Oncology·MeSH: Testicular Neoplasms
Prevalence
143.5 / 100K
Incidence
18.4 / 100K/yr
548 drugs in development·101 companies·1 clinical trial
Drug Pipeline by Phase
Approved(27)
Phase 3(133)
Phase 2(122)
Phase 1(123)
Preclinical(18)
Unknown(11)
Phase 1/Phase 2(51)
Phase 2/Phase 3(3)
Phase 4(58)
Compare drugs
Frequently asked questions
How many drugs are in development for Prostate?
BioSniper tracks 548 drugs in development for Prostate across 101 companies.
How many clinical trials target Prostate?
There are 1 clinical trial targeting Prostate tracked by BioSniper.
What is the prevalence of Prostate?
The estimated prevalence of Prostate is approximately 143.5 per 100,000 population.
Deep-dive into Prostate
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis